These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19126808)

  • 21. [Complete hormonal block vs. simple hormonal block in the treatment of carcinoma of the prostate].
    Berenguer Sánchez A
    Arch Esp Urol; 2002 Sep; 55(7):771-5. PubMed ID: 12380304
    [No Abstract]   [Full Text] [Related]  

  • 22. [Management of a hormone dependent cancer with endocrine therapy--prostate cancer].
    Tsukamoto S; Akaza H
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):917-26. PubMed ID: 11478140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Combined treatment of metastatic hormone-resistant prostate cancer].
    Kaprin AD; Gafanov RA; Al'bitskiĭ IA; Fastovets SV
    Vopr Onkol; 2009; 55(4):477-9. PubMed ID: 19947375
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of prostate cancer].
    Romics I
    Orv Hetil; 2010 Apr; 151(14):580-3. PubMed ID: 20332076
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of hormonal treatment in prostate cancer.
    Flüchter SH; Weiser R; Gamper C
    Recent Results Cancer Res; 2007; 175():211-37. PubMed ID: 17432562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The benefits of early androgen blockade.
    Maroni PD; Crawford ED
    Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):317-29. PubMed ID: 18471789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Steroid hormone withdrawal syndromes. Pathophysiology and clinical significance.
    Kelly WK; Slovin S; Scher HI
    Urol Clin North Am; 1997 May; 24(2):421-31. PubMed ID: 9126240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overview of hormonal therapy for prostate cancer.
    Carter HB; Isaacs JT
    Prog Clin Biol Res; 1990; 350():129-40. PubMed ID: 2201039
    [No Abstract]   [Full Text] [Related]  

  • 29. Prostate cancer, osteoporosis and fracture risk.
    Allain TJ
    Gerontology; 2006; 52(2):107-10. PubMed ID: 16508318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complete hormonal blockage--antiandrogens.
    Bierkens AF; Debruyne FM
    Acta Urol Belg; 1996 May; 64(2):77-9. PubMed ID: 8701818
    [No Abstract]   [Full Text] [Related]  

  • 31. [Bicalutamide].
    Kotake T
    Nihon Rinsho; 2000 Jul; 58 Suppl():216-22. PubMed ID: 11022717
    [No Abstract]   [Full Text] [Related]  

  • 32. Intermittent androgen deprivation therapy: clarity from confusion.
    Klotz L
    Eur Urol; 2013 Nov; 64(5):731-3. PubMed ID: 23866956
    [No Abstract]   [Full Text] [Related]  

  • 33. Multiple intracrine hormonal targets in the prostate: opportunities and challenges.
    Labrie F
    BJU Int; 2007 Jul; 100 Suppl 2():48-51. PubMed ID: 17594360
    [No Abstract]   [Full Text] [Related]  

  • 34. [Neoadjuvant hormonal treatment combined with external irradiation in the management of prostate cancer].
    Bolla M; Artignan X; Fourneret P; Brochon D; Ringeisen F; Descotes JL
    Bull Cancer; 2006 Nov; 93(11):1101-5. PubMed ID: 17145579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Piecewise affine systems modelling for optimizing hormone therapy of prostate cancer.
    Suzuki T; Bruchovsky N; Aihara K
    Philos Trans A Math Phys Eng Sci; 2010 Nov; 368(1930):5045-59. PubMed ID: 20921011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Androgen deprivation therapy and cardiovascular risk.
    Rees J
    Practitioner; 2015 Sep; 259(1785):5. PubMed ID: 26591651
    [No Abstract]   [Full Text] [Related]  

  • 37. The androgen receptor for the radiation oncologist.
    Quero L; Rozet F; Beuzeboc P; Hennequin C
    Cancer Radiother; 2015 May; 19(3):220-7. PubMed ID: 25921704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evolution of endocrine therapy for prostate cancer].
    Igawa T; Saito Y
    Nihon Rinsho; 2000 Jul; 58 Suppl():176-81. PubMed ID: 11022709
    [No Abstract]   [Full Text] [Related]  

  • 39. Prostate cancer drugs. Making sense of the options.
    Mayo Clin Health Lett; 2003 Aug; 21(8):4-5. PubMed ID: 12971308
    [No Abstract]   [Full Text] [Related]  

  • 40. Hormonal treatment of prostate cancer.
    Garnick MB
    N Engl J Med; 1999 Mar; 340(10):812-3. PubMed ID: 10075531
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.